
TSPA invests in US-listed companies in an attempt to provide exposure similar to its benchmark, the S&P 500 an index composed of the 500 largest publicly traded US firms. The fund aims to be sector neutral by weighting each industry close to the index, while seeking to outperform it by overweighting or underweighting individual holdings based on fundamental research, which measures how favorable each stock is. Unlike other ETFs that publish full portfolio holdings daily, TSPA publishes a proxy portfolio on its website. The proxy portfolio is a basket of securities designed to closely track…
Is TSPA's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.


Good forecasting starts with a willingness to admit mistakes, according to Dan Gardner, co-author of “Superforecasting: The Art and Science of Prediction.” Key Takeaways: Superforecasters made frequent but small updates to their predictions, avoiding both stubbornness and overreaction to new information.

Shares of T. Rowe Price U.S. Equity Research ETF (NYSEARCA:TSPA - Get Free Report) hit a new 52-week high on Monday. The stock traded as high as $49.19 and last traded at $49.19, with a volume of 191719 shares. The stock had previously closed at $48.74. T. Rowe Price U.S. Equity Research ETF Stock Performance

T. Rowe Price U.S. Equity Research ETF (NYSEARCA:TSPA - Get Free Report) saw strong trading volume on Monday. 1,019,538 shares traded hands during mid-day trading, an increase of 173% from the previous session's volume of 374,107 shares. The stock last traded at $48.4490 and had previously closed at $48.83. T. Rowe Price U.S. Equity Research

T. Rowe Price Group launched three active equity ETFs Thursday. The funds target biotechnology, small-cap and mid-cap stocks, the company said.